478
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Formulation and statistical optimization of intravenous temozolomide-loaded PEGylated liposomes to treat glioblastoma multiforme by three-level factorial design

, , &
Pages 923-933 | Received 10 Jul 2017, Accepted 21 Dec 2017, Published online: 09 Jan 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Tejashree Waghule, Ranendra Narayan Saha & Gautam Singhvi. (2023) Exploring microfluidics and membrane extrusion for the formulation of temozolomide-loaded liposomes: investigating the effect of formulation and process variables. Journal of Liposome Research 33:2, pages 170-182.
Read now
Jiefen Yang, Youfa Xu, Zhiqin Fu, Jianming Chen, Wei Fan & Xin Wu. (2023) Progress in research and development of temozolomide brain-targeted preparations: a review. Journal of Drug Targeting 31:2, pages 119-133.
Read now
Tejashree Waghule, Vamshi Krishna Rapalli, Gautam Singhvi, Srividya Gorantla, Archana Khosa, Sunil Kumar Dubey & Ranendra Narayan Saha. (2021) Design of temozolomide-loaded proliposomes and lipid crystal nanoparticles with industrial feasible approaches: comparative assessment of drug loading, entrapment efficiency, and stability at plasma pH. Journal of Liposome Research 31:2, pages 158-168.
Read now
Nagat El Demerdash, Jayanidhi Kedda, Nivi Ram, Henry Brem & Betty Tyler. (2020) Novel therapeutics for brain tumors: current practice and future prospects. Expert Opinion on Drug Delivery 17:1, pages 9-21.
Read now

Articles from other publishers (21)

Zahra Nozhat, Shabnam Heydarzadeh, Mina Shahriari-Khalaji, Shibo Wang, M. Zubair Iqbal & Xiangdong Kong. (2023) Advanced biomaterials for human glioblastoma multiforme (GBM) drug delivery. Biomaterials Science 11:12, pages 4094-4131.
Crossref
Jigar D. Vanza, Jigar R. Lalani, Rashmin B. Patel & Mrunali R. Patel. (2023) DOE supported optimization of biodegradable polymeric nanoparticles based dry powder inhaler for targeted delivery of afatinib in non-small cell lung cancer. Journal of Drug Delivery Science and Technology 84, pages 104554.
Crossref
MANSING PATIL & PINKAL PATEL. (2023) LIPOSOMAL DRY POWDER INHALER: NOVEL PULMONARY TARGETED DRUG DELIVERY SYSTEM FOR THE TREATMENT OF LUNG CANCER. International Journal of Applied Pharmaceutics, pages 1-12.
Crossref
Margarita E. Neganova, Yulia R. Aleksandrova, Olga A. Sukocheva & Sergey G. Klochkov. (2022) Benefits and limitations of nanomedicine treatment of brain cancers and age-dependent neurodegenerative disorders. Seminars in Cancer Biology 86, pages 805-833.
Crossref
Jigar D. Vanza, Dhwani M. Shah, Rashmin B. Patel & Mrunali R. Patel. (2022) Afatinib liposomal dry powder inhaler: Targeted pulmonary delivery of EGFR inhibitor for the management of lung cancer. Journal of Drug Delivery Science and Technology 74, pages 103506.
Crossref
Ankit Javia, Ambikanandan Misra & Hetal Thakkar. (2022) Liposomes encapsulating novel antimicrobial peptide Omiganan: Characterization and its pharmacodynamic evaluation in atopic dermatitis and psoriasis mice model. International Journal of Pharmaceutics 624, pages 122045.
Crossref
Zahra Karimi, Somayeh Taymouri, Mohsen Minaiyan & Mina Mirian. (2022) Evaluation of thermosensitive chitosan hydrogel containing gefitinib loaded cellulose acetate butyrate nanoparticles in a subcutaneous breast cancer model. International Journal of Pharmaceutics 624, pages 122036.
Crossref
Jessyca Aparecida Paes Dutra, Marcela Tavares Luiz, Alberto Gomes Tavares Junior, Leonardo Delello Di Filippo, Suzana Gonçalves Carvalho & Marlus Chorilli. (2022) Temozolomide: An Overview of Biological Properties, Drug Delivery Nanosystems, and Analytical Methods. Current Pharmaceutical Design 28:25, pages 2073-2088.
Crossref
Daria Petrenko, Vladimir Chubarev, Nikita Syzrantsev, Nafeeza Ismail, Vadim Merkulov, Susanna Sologova, Ekaterina Grigorevskikh, Elena Smolyarchuk & Renad Alyautdin. (2022) Temozolomide Efficacy and Metabolism: The Implicit Relevance of Nanoscale Delivery Systems. Molecules 27:11, pages 3507.
Crossref
Sudarvizhi Thanigainathan, Sangamithra Ramalingan, Subramanianainar Meyyanathan & Basavan Babu. (2022) QbD Approach For Anti-Cancer Drugs - A Review. Current Pharmaceutical Analysis 18:3, pages 251-264.
Crossref
Roxana-Maria Amarandi, Alina Ibanescu, Eugen Carasevici, Luminita Marin & Brindusa Dragoi. (2022) Liposomal-Based Formulations: A Path from Basic Research to Temozolomide Delivery Inside Glioblastoma Tissue. Pharmaceutics 14:2, pages 308.
Crossref
Tejashree Waghule, Ranendra Narayan Saha & Gautam Singhvi. (2021) UV spectroscopic method for estimation of temozolomide: Application in stability studies in simulated plasma pH, degradation rate kinetics, formulation design, and selection of dissolution media. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 258, pages 119848.
Crossref
P. Soma Yasaswi, Karishma Shetty & Khushwant S. Yadav. (2021) Temozolomide nano enabled medicine: promises made by the nanocarriers in glioblastoma therapy. Journal of Controlled Release 336, pages 549-571.
Crossref
Poonam Negi, Chetna Hemrajani & Shweta Agarwal. 2021. Design of Experiments for Pharmaceutical Product Development. Design of Experiments for Pharmaceutical Product Development 129 150 .
Eilam Yeini, Paula Ofek, Nitzan Albeck, Daniel Rodriguez Ajamil, Lena Neufeld, Anat Eldar‐Boock, Ron Kleiner, Daniella Vaskovich, Shani Koshrovski‐Michael, Sahar Israeli Dangoor, Adva Krivitsky, Christian Burgos Luna, Gal Shenbach‐Koltin, Miki Goldenfeld, Ori Hadad, Galia Tiram & Ronit Satchi‐Fainaro. (2020) Targeting Glioblastoma: Advances in Drug Delivery and Novel Therapeutic Approaches. Advanced Therapeutics 4:1, pages 2000124.
Crossref
Jigar D. Vanza, Rashmin B. Patel & Mrunali R. Patel. (2020) Nanocarrier centered therapeutic approaches: Recent developments with insight towards the future in the management of lung cancer. Journal of Drug Delivery Science and Technology 60, pages 102070.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Particulate systems for improving therapeutic efficacy of pharmaceuticals against central nervous system-related diseases. Journal of the Taiwan Institute of Chemical Engineers 114, pages 12-23.
Crossref
Yung-Chih Kuo & Rajendiran Rajesh. (2020) Biomaterial-based drug delivery systems used to improve chemotherapeutic activity of pharmaceuticals and to target inhibitors of apoptosis proteins. Journal of the Taiwan Institute of Chemical Engineers 111, pages 1-10.
Crossref
Ioanna Theochari, Aristotelis Xenakis & Vassiliki Papadimitriou. 2020. Smart Nanocontainers. Smart Nanocontainers 315 341 .
Parva Jani, Jigar Vanza, Nilima Pandya & Hemal Tandel. (2019) Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery. Therapeutic Delivery 10:11, pages 683-696.
Crossref
Asiya Mahtab, Md. Rizwanullah, Shweta Pandey, Ankita Leekha, Syed Arman Rabbani, Anita Kamra Verma, Mohd. Aqil & Sushama Talegaonkar. (2019) Quality by design driven development and optimization of teriflunomide loaded nanoliposomes for treatment of rheumatoid arthritis: An in vitro and in vivo assessments. Journal of Drug Delivery Science and Technology 51, pages 383-396.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.